(Q24241305)

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Success and failure at inpatient heroin detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Efficacy of methadone versus methadone and guanfacine in the detoxification of heroin-addicted patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Lofexidine versus clonidine in rapid opiate detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Clonidine blocks acute opiate-withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Effect of methadone dosage on clonidine detoxification efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Comparison of acetorphan with clonidine for opiate withdrawal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Nimodipine in opiate detoxification: a controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Primary care-based ambulatory opioid detoxification: the results of a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Three methods of opioid detoxification in a primary care setting. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Type of hospital setting and treatment outcome with heroin addicts. Results from a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

A controlled comparison of clonidine and doxepin in the treatment of the opiate withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Methadone at tapered doses for the management of opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Inpatient versus other settings for detoxification for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

The neurobiological implication of clonidine HCl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Clonidine and the treatment of the opiate withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Buprenorphine for the management of opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Trends in opiate overdose deaths in Australia 1979-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

The economic costs of heroin addiction in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Are detoxification programmes effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Pharmacological advances in addiction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Should protracted withdrawal from drugs be included in DSM-IV?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Clonidine transdermal patches for use in outpatient opiate withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

What can long-term follow-up teach us about relapse and prevention of relapse in addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

Clonidine in outpatient detoxification from methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Clonidine in morphine withdrawal. Differential effects on signs and symptoms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

THE ASSOCIATION CARBAMAZEPINE-MIANSERIN IN OPIATE WITHDRAWAL: A DOUBLE BLIND PILOT STUDY VERSUS CLONIDINE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Relationship of depression to clonidine detoxification of opiate addicts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Methadone combined with clonidine versus clonidine alone in opiate detoxification

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

The Atwood Hall Health Promotion Program, Federal Medical Center, Lexington, KY. Effects on drug-involved federal offenders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Clonidine versus methadone for opiate detoxification

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Clonidine in heroin withdrawal syndrome: a controlled study in India

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

The use of lofexidine by drug dependency units in the United Kingdom

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

The influence of psychological factors on the opiate withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Clonidine versus long- and short-term methadone-aided withdrawal from opiates. An uncontrolled comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021

Audit of the in-patient management of opioid withdrawal using lofexidine hydrochloride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002024.PUB3

7 January 2021